The initial factor in indicating the glioma variety is the isocitrate dehydrogenase (IDH) mutation status: glioblastoma—wild-type IDH (IHDwt) and oligodendroglioma or astrocytoma—IDH-mutant. The gene discussed is IDH1; the disease is central nervous system cancer.